Published in Ultrasound Obstet Gynecol on May 01, 2006
Fetal MRI in the evaluation of fetuses referred for sonographically suspected neural tube defects (NTDs): impact on diagnosis and management decision. Neuroradiology (2009) 0.84
Objective evaluation of sylvian fissure development by multiplanar 3-dimensional ultrasonography. J Ultrasound Med (2007) 0.79
Three-dimensional sagittal reconstruction of the corpus callosum: fact or artifact? Ultrasound Obstet Gynecol (2006) 0.77
Imaging the fetal central nervous system. Facts Views Vis Obgyn (2011) 0.75
KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer. Br J Cancer (2009) 3.73
Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol (2012) 2.07
Miltefosine for new world cutaneous leishmaniasis. Clin Infect Dis (2004) 2.02
Potential utility of early metabolic response by 18F-2-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in a selected group of breast cancer patients receiving preoperative chemotherapy. Eur J Cancer (2013) 2.01
Antigen retrieval techniques in immunohistochemistry: comparison of different methods. J Pathol (1997) 2.01
Horizontal stomach: a new sonographic clue to the antenatal diagnosis of right-sided congenital diaphragmatic hernia. Ultrasound Obstet Gynecol (2013) 2.00
Prenatal diagnosis of isolated butterfly vertebra. Ultrasound Obstet Gynecol (2014) 1.98
The basal-like breast carcinoma phenotype is regulated by SLUG gene expression. J Pathol (2008) 1.83
Idiosyncratic reaction after oxaliplatin infusion. Ann Oncol (2001) 1.63
Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan. Pharmacogenomics J (2010) 1.63
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions. Radiol Med (2007) 1.58
The clinical significance of fetal isolated cerebral borderline ventriculomegaly: report of 31 cases and review of the literature. Ultrasound Obstet Gynecol (1999) 1.53
Outcome of antenatally diagnosed intracranial hemorrhage: case series and review of the literature. Ultrasound Obstet Gynecol (2003) 1.48
Management of intrahepatic cholestasis in pregnancy. Lancet (1992) 1.44
Pathologic correlates of diffusion MRI changes in Creutzfeldt-Jakob disease. Neurology (2009) 1.44
Onychoblastoma (hamartoma of the nail unit): a new entity? Br J Dermatol (2005) 1.43
Gastrointestinal autonomic nerve tumor of the jejunum. Case report and review of the literature. Ital J Gastroenterol Hepatol (1997) 1.42
Endocrine pancreatic tumors: factors correlated with survival. Ann Oncol (2005) 1.41
Leiomyomatosis in pelvic lymph nodes. Histopathology (1992) 1.39
High prevalence of retinoblastoma protein loss in triple-negative breast cancers and its association with a good prognosis in patients treated with adjuvant chemotherapy. Ann Oncol (2009) 1.34
Intrinsic intrathoracic malformations of the fetus: sonographic detection and clinical presentation. Obstet Gynecol (1987) 1.32
Congenital colonic stenosis: a case of late-onset. Pediatr Med Chir (2009) 1.24
Reproduction in Down syndrome. Obstet Gynecol (1982) 1.23
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy. Pharmacogenomics J (2007) 1.20
Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer. J Pathol (2006) 1.20
Paraovarian/paratubal cysts: comparison of transvaginal sonographic and pathological findings to establish diagnostic criteria. Ultrasound Obstet Gynecol (2006) 1.20
The role of Aurora-A inhibitors in cancer therapy. Ann Oncol (2007) 1.16
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial. Br J Cancer (2006) 1.14
Prenatal diagnosis of microcephaly assisted by vaginal sonography and power Doppler. Ultrasound Obstet Gynecol (1998) 1.13
Dieulafoy's disease associated with early gastric cancer. J Clin Pathol (1995) 1.13
Clone heterogeneity in diploid and aneuploid breast carcinomas as detected by FISH. Cytometry (2001) 1.11
Change of Th0 to Th1 cell-cytokine profile following tuberculosis chemotherapy. Scand J Immunol (2000) 1.08
Diagnosis of station and rotation of the fetal head in the second stage of labor with intrapartum translabial ultrasound. Ultrasound Obstet Gynecol (2009) 1.08
Prenatal diagnosis and outcome of fetal posterior fossa fluid collections. Ultrasound Obstet Gynecol (2012) 1.07
Diagnosis and significance of cystic hygroma in the first trimester. Prenat Diagn (1990) 1.07
Empty sella in children and adolescents with possible hypothalamic-pituitary disorders. J Clin Endocrinol Metab (1994) 1.06
Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I. Am J Surg Pathol (1997) 1.06
CNS involvement in primary Sjögren's syndrome: prevalence, clinical aspects, diagnostic assessment and therapeutic approach. CNS Drugs (2001) 1.05
Villin, intestinal brush border hydrolases and keratin polypeptides in intestinal metaplasia and gastric cancer; an immunohistologic study emphasizing the different degrees of intestinal and gastric differentiation in signet ring cell carcinomas. Virchows Arch A Pathol Anat Histopathol (1988) 1.05
Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients. Br J Cancer (2005) 1.05
Adjuvant colon cancer chemotherapy: where we are and where we'll go. Cancer Treat Rev (2010) 1.05
Apoptosis: a relevant tool for anticancer therapy. Ann Oncol (2006) 1.05
Nuclear receptors agonists exert opposing effects on the inflammation dependent survival of breast cancer stem cells. Cell Death Differ (2012) 1.05
Ultrasound monitoring of ovarian follicular development: a comparison real-time and static scanning techniques. J Clin Ultrasound (1983) 1.04
Fetal cardiac abnormalities identified prior to 14 weeks' gestation. Ultrasound Obstet Gynecol (2002) 1.03
Giant mucocele of the appendix: report of a case. Dis Colon Rectum (2001) 1.02
Distribution and viral load of type specific HPVs in different cervical lesions as detected by PCR-ELISA. J Clin Pathol (2001) 1.02
Second-line chemotherapy for patients with advanced gastric cancer: who may benefit? Br J Cancer (2008) 1.01
Cyclo-oxygenase-2 (COX-2) expression at the site of recent myocardial infarction: friend or foe? Heart (2004) 1.00
Cell cycle alterations and lung cancer. Histol Histopathol (2006) 0.99
Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers. Hepatology (2001) 0.99
Organization and activities of the International Radio Medical Centre (CIRM). J Telemed Telecare (1996) 0.98
Beta-galactoside alpha2,6 sialyltransferase in human colon cancer: contribution of multiple transcripts to regulation of enzyme activity and reactivity with Sambucus nigra agglutinin. Int J Cancer (2000) 0.98
Prediction of pre-eclampsia by an analysis of placenta-derived cellular mRNA in the blood of pregnant women at 15-20 weeks of gestation. BJOG (2010) 0.97
Bisphosphonates: new antiangiogenic molecules in cancer treatment? Ann Oncol (2003) 0.97
Idiopathic myenteric ganglionitis underlying intractable vomiting in a young adult. Eur J Gastroenterol Hepatol (2000) 0.97
Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype. Ann Oncol (2005) 0.97
Role of KRAS let-7 LCS6 SNP in metastatic colorectal cancer patients. Ann Oncol (2010) 0.96
Colorectal carcinomas and PTEN/MMAC1 gene mutations. Clin Cancer Res (2001) 0.96
Correlation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinico-pathological features in colon cancer. Cancer Lett (2004) 0.96
AgNORs in breast tumours. Micron (2000) 0.96
ISUOG practice guidelines: performance of first-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol (2013) 0.96
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features. Histopathology (2005) 0.96
Guillotine needle biopsy as a supplement to endosonography in the diagnosis of gastric submucosal tumors. Endoscopy (1991) 0.95
Primary empty sella: differences and similarities between children and adults. Acta Paediatr (1995) 0.95
Absence of the ductus venosus: report of 10 new cases and review of the literature. Ultrasound Obstet Gynecol (2001) 0.95
Prenatal diagnosis of thrombosis of the dural sinuses with real-time and color Doppler ultrasound. Ultrasound Obstet Gynecol (2001) 0.94
Esophageal leiomyomatosis in children: report of a case and review of the literature. Eur J Pediatr Surg (1998) 0.94
Congenital cytomegalovirus infection: patterns of fetal brain damage. Clin Microbiol Infect (2012) 0.94
Sonography of fetal agenesis of the corpus callosum: a survey of 35 cases. Ultrasound Obstet Gynecol (1993) 0.93
p16(INK4A) expression is related to grade of cin and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome. Int J Gynecol Pathol (2004) 0.93
Expression of AP-2 transcription factor and of its downstream target genes c-kit, E-cadherin and p21 in human cutaneous melanoma. J Cell Biochem (2001) 0.93
Retinoblastoma (RB1) gene product expression in breast carcinoma. Correlation with Ki-67 growth fraction and biopathological profile. J Clin Pathol (1998) 0.92
Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer. Ann Oncol (2011) 0.92
Laparoscopic repair of Morgagni-Larrey hernia in a child. J Pediatr Surg (2000) 0.92
Sonography of pregnancies with first-trimester bleeding and a viable embryo: a study of prognostic indicators by logistic regression analysis. Ultrasound Obstet Gynecol (1996) 0.92
Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancer. Eur J Obstet Gynecol Reprod Biol (2006) 0.92
Oxaliplatin may induce cytokine-release syndrome in colorectal cancer patients. J Biol Regul Homeost Agents (2002) 0.92
Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type. Am J Pathol (1997) 0.92
Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs. Endocr Relat Cancer (2008) 0.91
Nanotech revolution for the anti-cancer drug delivery through blood-brain barrier. Curr Cancer Drug Targets (2012) 0.91
Inadequate drug advice in the pharmacies of Guatemala and Mexico: the scale of the problem and explanatory factors. Ann Trop Med Parasitol (2001) 0.91
Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study. Eur J Gynaecol Oncol (2004) 0.90
Tolerance to the protective effect of salmeterol on allergen challenge. Chest (1996) 0.90
Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD). Ann Oncol (2002) 0.90
Population pharmacokinetic study of teicoplanin in severely neutropenic patients. Antimicrob Agents Chemother (1996) 0.90
Immunohistochemistry of bone-marrow biopsy. Leuk Lymphoma (1997) 0.89
Upregulation of telomerase (hTERT) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus, virus persistence, or disease outcome in cervical cancer. Diagn Cytopathol (2006) 0.89
CD44 isoform 6 (CD44v6) is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma. Gynecol Oncol (2001) 0.89
Cell cycle related proteins as prognostic parameters in radically resected non-small cell lung cancer. J Clin Pathol (2005) 0.89
Quantitative p21(waf-1)/p53 immunohistochemical analysis defines groups of primary invasive breast carcinomas with different prognostic indicators. Int J Cancer (2001) 0.89
Neoadjuvant chemotherapy in cervical carcinoma: regulators of cell cycle, apoptosis, and proliferation as determinants of response to therapy and disease outcome. Am J Clin Pathol (2001) 0.89
The prognostic value of the AgNOR parameter in human breast cancer depends on the pRb and p53 status. J Clin Pathol (2004) 0.89
Intrapartum transperineal ultrasound assessment of fetal head progression in active second stage of labor and mode of delivery. Ultrasound Obstet Gynecol (2013) 0.88